Brief: Oncolytics Biotech Q1 loss per share $0.03
May 5 (Reuters) - Oncolytics Biotech Inc ONC.TO
* Oncolytics Biotech Inc. Announces 2017 first quarter
results
* Qtrly loss per share $0.03
Source text for Eikon: ID:nPn36fM0Ha
Further company coverage: ONC.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma
Brief: Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal Cancer
Brief: Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026
Brief: Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update
Brief: Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer